Tulavi Therapeutics
Tulavi Therapeutics is a medical device company specializing in solutions for peripheral nerve surgery. The company focuses on developing absorbable hydrogel-based technologies to optimize nerve recovery, reduce the risk of neuroma formation, and improve patient outcomes. Its platform leverages in situ forming, sutureless biomaterials suitable for a variety of nerve injuries, addressing critical gaps in current surgical care. Tulavi is committed to innovation, clinical evidence, and accessibility for both adult and pediatric populations.
Industries
N/A
Tulavi Therapeutics
Patents
Treatment of sepsis and related inflammatory conditions by local neuromodulation of the autonomic nervous system
2024-07-09 • US-12029733-B2
View DetailsMethods, agents, and devices for local neuromodulation of autonomic nerves
2024-03-05 • US-11918595-B2
View Details
Treatment of sepsis and related inflammatory conditions by local neuromodulation of the autonomic nervous system
2024-07-09 • US-12029733-B2
View DetailsMethods, agents, and devices for local neuromodulation of autonomic nerves
2024-03-05 • US-11918595-B2
View DetailsProducts
A sutureless, fully absorbable hydrogel device forming in situ to protect transected peripheral nerves and reduce the risk of symptomatic neuroma formation. Remains in place for approximately eight months and conforms to various nerve sizes.
A sutureless, fully absorbable hydrogel device forming in situ to protect transected peripheral nerves and reduce the risk of symptomatic neuroma formation. Remains in place for approximately eight months and conforms to various nerve sizes.
Expertise Areas
- Peripheral nerve surgery
- Biomaterials engineering
- Clinical research for medical devices
- Absorbable device design
Key Technologies
- In situ forming hydrogel
- Absorbable biomaterials
- Nerve barrier device platforms
- Sutureless application systems
Key People
Chief Executive Officer
Chairman & Co-Founder
Delos Capital, Board Member
Board Member, Incept LLC
Director - Ascension Ventures, Board Member
Independent Director
Chief Executive Officer
Chairman & Co-Founder
Delos Capital, Board Member
Board Member, Incept LLC
Director - Ascension Ventures, Board Member
Independent Director
News & Updates
Published in PRS Global Open, the first peer-reviewed clinical data for the absorbable hydrogel nerve cap demonstrates safety and efficacy in early clinical use.
Received Innovative Technology contract from Vizient for absorbable hydrogel nerve cap, identifying technology as having potential to improve clinical care and healthcare operations.
Publication of initial peer-reviewed clinical data for absorbable hydrogel nerve cap in Plastic and Reconstructive Surgery Global Open journal.
Expanded the indication for absorbable hydrogel nerve cap to include patients weighing 25 kg (55 lbs) and above.
Selected to exhibit absorbable hydrogel nerve cap at Vizient Innovative Technology Exchange.
Formed a partnership with Veterans Healthcare Supply Solutions to distribute absorbable hydrogel nerve cap to U.S. VA hospitals and military treatment facilities.
Published in PRS Global Open, the first peer-reviewed clinical data for the absorbable hydrogel nerve cap demonstrates safety and efficacy in early clinical use.
Received Innovative Technology contract from Vizient for absorbable hydrogel nerve cap, identifying technology as having potential to improve clinical care and healthcare operations.
Publication of initial peer-reviewed clinical data for absorbable hydrogel nerve cap in Plastic and Reconstructive Surgery Global Open journal.
Expanded the indication for absorbable hydrogel nerve cap to include patients weighing 25 kg (55 lbs) and above.
Selected to exhibit absorbable hydrogel nerve cap at Vizient Innovative Technology Exchange.
Formed a partnership with Veterans Healthcare Supply Solutions to distribute absorbable hydrogel nerve cap to U.S. VA hospitals and military treatment facilities.